Skip to main content
. Author manuscript; available in PMC: 2012 Apr 1.
Published in final edited form as: J Hepatol. 2010 Oct 23;54(4):695–704. doi: 10.1016/j.jhep.2010.10.004

Figure 1.

Figure 1

Schematic representation of the World Health Organization (WHO) and European Association for Study of the Liver (EASL) guidelines. The WHO guidelines suggest measurement of the whole tumor irrespective of the amount of necrosis (black) seen. The EASL guidelines suggest measurement of the enhancing tissue only (grey). This figure represents the discordance between the two guidelines.